arrow
Y

Yilv Yan

Tongji University School of Medicine
H指数:9
被引数:1,927

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neoadjuvant PD-1 Blockade Tislelizumab (BGB-A317) in Combination With Etoposide and Platinum-Based Chemotherapy for Limited-Disease Small Cell Lung Cancer

PD-1阻断剂替雷利珠单抗(BGB-A317)联合依托泊苷和铂类为基础的化疗用于局限期小细胞肺癌的新辅助治疗

MedComm
IF10.7
2026-09-050
OAAI
Surgery after induced anti-PD-L1 therapy and chemotherapy for stage I‒III small-cell lung cancer: a phase 2 trial (LungMate-005)

诱导抗PD-L1治疗和化疗后对I‒III期小细胞肺癌进行手术:一项II期试验(LungMate-005)

2025-11-250
OAAI
Ubiquitin-Specific Protease 7-Mediated Stabilization of Discoidin Domain Receptor 1 Drives Progression of TP53-Mutant Cancers

泛素特异性蛋白酶7介导的 discsoidin 结构域受体1稳定化驱动TP53突变型癌症的进展

2025-07-240
OA
Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial

基于PD1抗体的精准诱导疗法在不可切除的III期非小细胞肺癌中的应用:一项II期伞式临床试验

2025-02-240
OA
Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing

单细胞RNA测序揭示非小细胞肺癌新辅助免疫治疗后肿瘤微环境重塑

2023-03-0380
OAAI